Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment
To date, 30 crore vaccines have been produced as part of the commitment made to the Government of India
Novartis data again demonstrate age-appropriate development when Zolgensma is used presymptomatically, and post-hoc data reveal SMA Type 1 patients could speak, swallow and maintain airway protection
Casimir further differentiates Emmes’ industry-leading rare disease research capabilities
Intranasal immunization lowers the viral load below the limit of detection in lungs of hamsters
It is a Phase 3 ready anti-myostatin adnectin for Spinal Muscular Atrophy (SMA).
It is India’s 1st indigenously developed Receptor Binding Domain Protein sub-unit vaccine against Covid-19
Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered
NDM disorders are a group of rare, inherited neuromuscular disorders which is characterized by the inability to relax muscles following voluntary contraction
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius
Subscribe To Our Newsletter & Stay Updated
